Combination Drug Delivery Approach as an Effective Therapy for Various Diseases

Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community.

Section 1: Combination drug delivery approaches against various diseases 1. Drug resistance as challenges to effective therapy 2. Overcoming the challenges of drug resistance through combination drug delivery approach 3. Combination drug delivery approaches for pulmonary diseases 4. Combination drug delivery approaches in ophthalmology 5. Combination drug delivery system to enhance the transdermal drug delivery 6. Combination drug delivery approaches in arthritis rheumatoid and osteoarthritis 7. Combination drug delivery approaches for cardiovascular disease 8. Combination drug delivery approaches for viral infection 9. Combination drug delivery approaches for malaria parasite 10. Combination drug delivery approaches for tuberculosis

Section 2: Combination drug delivery approaches against cancer 11. Combination drug delivery approaches for cancer therapy 12. Prodrug-based drug delivery approaches in cancer combination therapy 13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics 14. Cocktail chemotherapy by combination drug delivery systems 15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy 16. Combinational chemotherapy and hyperthermia in cancer treatment

Section 3: Combination drug delivery approaches challenges and future perspectives 17. Premarket review and postmarket regulation of combination drug products 18. Challenges associated with nanoparticulate combination drug delivery systems 19. Concluding remarks and future perspective of combination drug delivery systems